XML 69 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accounts receivable
 12 Months Ended
Dec. 31, 2023
Subclassifications of assets, liabilities and equities [abstract]  
Accounts receivable Accounts receivable
Accounts receivable break down as follows:
(€ million)December 31, 2023December 31, 2022December 31, 2021
Gross value8,528 8,537 7,705 
Allowances(95)(113)(137)
Carrying amount8,433 8,424 7,568 
The impact of allowances against accounts receivable in 2023 was a net expense of €8 million (versus a net amount of less than €1 million in 2022 and a net expense of €12 million in 2021).
The gross value of overdue receivables was €689 million as of December 31, 2023, versus €452 million as of December 31, 2022 and €455 million as of December 31, 2021.
Overdue accountsOverdue byOverdue byOverdue byOverdue byOverdue by
(€ million)gross value<1 month1 to 3 months3 to 6 months6 to 12 months> 12 months
December 31, 2023689 269 154 123 62 81 
December 31, 2022452 118 161 87 35 51 
December 31, 2021455 169 151 67 12 56 
Amounts overdue by more than one month relate mainly to public-sector customers.
Some Sanofi subsidiaries have assigned receivables to factoring companies or banks without recourse. The amount of receivables derecognized was €761 million as of December 31, 2023 (€131 million as of December 31, 2022 and €3 million as of December 31, 2021). The residual guarantees relating to such transfers were immaterial as of December 31, 2023.